NASDAQ: TARA - Protara Therapeutics, Inc.

Yield per half year: +171.43%
Dividend yield: 0.00%
Sector: Healthcare

Current price
4.15 $
Average price
5.2 $ +25.21%

Price based on EPS
3.89 $ -6.17%
Discount price Net Income
6.5 $ +56.59%
5/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 3.89 $
Current price = 4.15 $ (difference = -6.17%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -207.28 $
Current price = 4.15 $ (difference = -5 094.66%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -610.88 $
Current price = 4.15 $ (difference = -14 820.1%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription